Keywords
Cell Cycle Delayed
Cyclin D1
S Phase
Quiescent
Ubiquitous
Mitogen
Lung cancer
PI3K/AKT
How to Cite
Abstract
We previously reported on high expression of define PDCD2 in human malignancies. Knockdown of PDCD2 reduced the proliferation of leukemia and lung carcinoma cells. However, the mechanism by which PDCD2 reduces tumor proliferation remains unclear. This study tested the hypothesis that lowered PDCD2 would delay the proliferation of A549 lung carcinoma cells. Entry of A549 cells into S-phase was significantly (p-value 0.05) delayed when PDCD2 was knockdown. This correlated with a significant downregulation of cyclin D1, and AKT phosphorylation. Inhibition of the PI3K/AKT signaling pathway by Ly294002 decreased levels of PDCD2. These findings are consistent with a role for PDCD2 to mediate the entry of A549 cells into the cell cycle. Resting A549 cells showed PDCD2 localizing in the nucleus and plasma membrane and became diffuse with cell division, suggesting that PDCD2 is mitogen-dependent and may be involved in the proper timing of cell cycle. These findings may represent a promising venue to develop PDCD2 in clinical applications.
References
G.P. Owens, W.E. Hahn, J.J. Cohen, Identification of mRNAs associated with programmed cell death in immature thymocytes, Mol Cell Biol, 11 (1991) 4177–4188.
B.W. Baron, E. Hyjek, B. Gladstone, M.J. Thirman, J.M. Baron, PDCD2, a protein whose expression is repressed by BCL6, induces apoptosis in human cells by activation of the caspase cascade, Blood Cells Mol Dis, 45 (2002) 169–175.
B.W. Baron, J. Anastasi, M.J. Thirman, Y. Furukawa, S. Fears, D.C. Kim, F. Simone, M. Birkenbach, A. Montag, A. Sadhu, The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis, Proceedings of the National Academy of Sciences, 99 (2002) 2860–2865.
Q. Chen, K. Qian, C. Yan, Cloning of cDNAs with PDCD2 C domain and their expressions during apoptosis of HEK293T cells, Molecular and cellular biochemistry, 280 (2005) 185–191.
S. Minakhina, M. Druzhinina, R. Steward, Zfrp8, the Drosophila ortholog of PDCD2, functions in lymph gland development and controls cell proliferation, Development, 134 (2007) 2387–2396.
I. Guénal, B. Mignotte, Studies of specific gene induction during apoptosis of cell lines conditionally immortalized by SV40, FEBS letters, 374 (1995) 384–386.
D.L. Vaux, G. Hacker, Cloning of mouse RP-8 cDNA and its expression during apoptosis of lymphoid and myeloid cells, DNA and cell biology, 14 (1995) 189–193.
B.W. Baron, N. Zeleznik-Le, M.J. Baron, C. Theisler, D. Huo, M.D. Krasowski, M.J. Thirman, R.M. Baron, J.M. Baron, Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas, Proceedings of the National Academy of Sciences, 104 (2007) 7449–7454.
D. Steinemann, S. Gesk, Y. Zhang, L. Harder, C. Pilarsky, B. Hinzmann, J.I. Martin-Subero, M.J. Calasanz, A. Mungall, A. Rosenthal, Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms, Genes, Chromosomes and Cancer, 37 (2003) 421–426.
W. Mu, R.J. Munroe, A.K. Barker, J.C. Schimenti, PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance, Developmental biology, 347 (2010) 279–288.
J. Kramer, C.J. Granier, S. Davis, K. Piso, J. Hand, A.B. Rabson, H.E. Sabaawy, PDCD2 controls hematopoietic stem cell differentiation during development, Stem Cells Dev, 22 (2013) 58–72.
S. Minakhina, R. Steward, Hematopoietic stem cells in Drosophila, Development, 137 (2010) 27–31.
N.A. Kokorina, C.J. Granier, S.O. Zakharkin, S. Davis, A.B. Rabson, H.E. Sabaawy, PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells, Experimental hematology, 40 (2012) 1028–1042. e1023.
C.J. Granier, W. Wang, T. Tsang, R. Steward, H.E. Sabaawy, M. Bhaumik, A.B. Rabson, Conditional inactivation of PDCD2 induces p53 activation and cell cycle arrest, Biology open, 3 (2014) 821–831.
R.B. Scarr, P.A. Sharp, PDCD2 is a negative regulator of HCF-1 (C1), Oncogene, 21 (2002) 5245–5254.
H. Goto, S. Motomura, A.C. Wilson, R.N. Freiman, Y. Nakabeppu, K. Fukushima, M. Fujishima, W. Herr, T. Nishimoto, A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function, Genes and Development, 11 (1997) 726–737.
J. Wysocka, W. Herr, The herpes simplex virus VP16-induced complex: the makings of a regulatory switch, Trends in biochemical sciences, 28 (2003) 294–304.
S. Tyagi, A.L. Chabes, J. Wysocka, W. Herr, E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases, Molecular cell, 27 (2007) 107–119.
T. Heinzel, R.M. Lavinsky, T.-M. Mullen, M. Söderström, C.D. Laherty, J. Torchia, W.-M. Yang, G. Brard, S.D. Ngo, J.R. Davie, A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression, Nature, 387 (1997) 43–48.
B. Lutterbach, D. Sun, J. Schuetz, S.W. Hiebert, The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t (8; 21) fusion protein, Molecular and cellular biology, 18 (1998) 3604–3611.
N. Barboza, S. Minakhina, D.J. Medina, B. Balsara, S. Greenwood, L. Huzzy, A.B. Rabson, R. Steward, D.G. Schaar, PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia, Cancer biology & therapy, 14 (2013) 546–555.
J. Qian, G. Yehia, C.A. Molina, A. Fernandes, R.J. Donnelly, D.J. Anjaria, P. Gascon, P. Rameshwar, Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5’-monophosphate response elements in its expression by IL-1 and stem cell factor, The Journal of Immunology, 166 (2001) 2553–2561.
S.A. Patel, S.H. Ramkissoon, M. Bryan, L.F. Pliner, G. Dontu, P.S. Patel, S. Amiri, S.R. Pine, P. Rameshwar, Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy, Scientific reports, 2 (2012) 906.
J. Debnath, S.K. Muthuswamy, J.S. Brugge, Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures, Methods, 30 (2003) 256–268.
T.G. Graves, M.W. Harr, E.L. Crawford, J.C. Willey, Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control, Molecular cancer, 5 (2006) 1–13.
R.N. Gunawardane, S.B. Lizarraga, C. Wiese, A. Wilde, Y. Zheng, γ
-Tubulin complexes and their role in microtubule nucleation, Current topics in developmental biology, 49 (1999) 55–73.
B. Raynaud-Messina, A. Merdes, γ
-tubulin complexes and microtubule organization, Current opinion in cell biology, 19 (2007) 24–30.
X. Sun, P.D. Kaufman, Ki-67: more than a proliferation marker, Chromosoma, 127 (2018) 175–186.
F.A. Dick, S.M. Rubin, Molecular mechanisms underlying RB protein function, Nature reviews Molecular cell biology, 14 (2013) 297–306.
J.A. Diehl, M. Cheng, M.F. Roussel, C.J. Sherr, Glycogen synthase kinase-3β
regulates cyclin D1 proteolysis and subcellular localization, Genes & development, 12 (1998) 3499–3511.
J.A. Diehl, F. Zindy, C.J. Sherr, Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway, Genes & development, 11 (1997) 957–972.
L. Jirmanova, M. Afanassieff, S. Gobert-Gosse, S. Markossian, P. Savatier, Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells, Oncogene, 21 (2002) 5515–5528.
T. Kawakami, Y. Furukawa, K. Sudo, H. Saito, S. Takami, E. Takahashi, Y. Nakamura, Isolation and mapping of a human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death, Cytogenetic and Genome Research, 71 (1995) 41–43.
J.R. Alt, J.L. Cleveland, M. Hannink, J.A. Diehl, Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1–dependent cellular transformation, Genes & development, 14 (2000) 3102–3114.
D. Germain, A. Russell, A. Thompson, J. Hendley, Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286, Journal of Biological Chemistry, 275 (2000) 12074–12079.
K. Chen, X. Jiao, A. Di Rocco, D. Shen, S. Xu, A. Ertel, Z. Yu, G. Di Sante, M. Wang, Z. Li, Endogenous cyclin D1 promotes the rate of onset and magnitude of mitogenic signaling via Akt1 Ser473 phosphorylation, Cell reports, 32 (2020).
T. Sladek, E2F transcription factor action, regulation and possible role in human cancer, Cell proliferation, 30 (1997) 97–105.
J. Langenfeld, H. Kiyokawa, D. Sekula, J. Boyle, E. Dmitrovsky, Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism, Proceedings of the National Academy of Sciences, 94 (1997) 12070–12074.
J.P. Alao, The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention, Molecular cancer, 6 (2007) 1–16.
G. Watanabe, C. Albanese, R.J. Lee, A. Reutens, G. Vairo, B. Henglein, R.G. Pestell, Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1, Molecular and cellular biology, 18 (1998) 3212–3222.
A.C. Wilson, M. Boutros, K.M. Johnson, W. Herr, HCF-1 amino-and carboxy-terminal subunit association through two separate sets of interaction modules: involvement of fibronectin type 3 repeats, Molecular and Cellular Biology, 20 (2000) 6721–6730.
E. Julien, W. Herr, A switch in mitotic histone H4 lysine 20 methylation status is linked to M phase defects upon loss of HCF-1, Molecular cell, 14 (2004) 713–725.